Supplemental Figure 1
Figure S1 Spliceosome assembly pathway from the B complex to the ILS.
Supplemental Figure 2
Figure S2 Comparison of the growth of prp2-1 and prp2-1 Δsnu17 yeast strains at different temperatures. Yeast cultures were grown to saturation at 25°C and each strain was adjusted to a culture density of 0.4 at 600 nm. Serial 10-fold dilutions (rows from left to right) were spotted onto agar medium and incubated for 2 or 3 days at 16, 25, 30 or 37°C, as indicated.
Supplemental Figure 3
Figure S3 Brr2 unwinds U4/U6 in affinity-purified B complexes in a RESindependent manner. B complexes formed at 50 µM ATP in yeast extract from a prp2-1 strain (but without heat inactivation of Prp2) containing Snu17 (A-C) or lacking Snu17 (ΔRES) (D-F) were affinity purified, and subjected to a second glycerol gradient after incubation with (A, D) buffer, (B, E) 2 mM ATP or (C, F) ATP, Prp2 and Spp2. RNA was isolated and detected by Northern blotting with 32 P-labelled probes against the indicated snRNAs. The 32 P-actin pre-mRNA was detected by autoradiography. (G, H) RNA was isolated from B complexes formed in yeast extracts (G) with or (H) without Snu17, and analysed by native PAGE. U4 was visualized by Northern blotting.
Supplemental Figure 4
Figure S4 Prp2 RNA helicase facilitates the disassembly of purified ΔRES B complexes. B complexes formed in the presence of 50 µM ATP in yeast extracts from a prp2-1 strain (but without heat inactivation of Prp2) containing (A-C) or lacking Snu17 (Δsnu17) (D-F) were affinity purified, and subjected to a second glycerol gradient after incubation with (A, D) buffer, (B, E) 2 mM UTP or (C, F) UTP, Prp2 and Spp2. RNA was isolated from each gradient fraction, separated by denaturing PAGE and detected by Northern blotting with 32 P-labelled probes against the snRNAs indicated on the right. The 32 P-labelled actin pre-mRNA was detected by autoradiography. The % of the U2 snRNA and pre-mRNA in the boxed fractions is shown below in selected panels. act -like complexes formed in heat treated yeast extract from a prp2-1 Δsnu17 strain were affinity purified, and subjected to a second glycerol gradient after incubation with UTP, Prp2 and Spp2. RNA was analysed as described in the legend to Figure S3 .
Supplemental Figure 6
Figure S6 Analysis of U4/U6 duplex formation after incubation of ΔRES spliceosomes with UTP alone or UTP, Prp2 and Spp2. Affinity-purified ΔRES B/B act -like complexes were subjected to a second glycerol gradient after incubation with (A) 2 mM UTP or (B, C) UTP, Prp2 and Spp2. In panels A and B, RNA was isolated from each gradient fraction and analysed by native PAGE. In panel C, RNA was isolated from three pooled gradient fractions (as indicated above) and either analysed directly by denaturing PAGE (left half) or after incubation at 95°C to disrupt U4/U6 duplexes (right half). In all panels, free U4 snRNA or U4 base paired with U6 was subsequently visualized by Northern blotting with a 32 P-probe complementary to U4 snRNA.
Supplemental Figure 7
Figure S7 Immunoprecipitation of Snu114 containing complexes after incubation of ΔRES spliceosomes with UTP alone or UTP, Prp2 and Spp2. Affinity purified ΔRES B/B actlike complexes were subjected to a second glycerol gradient after incubation with (A, B) UTP or (C, D) UTP, Prp2 and Spp2. RNP complexes in gradient fractions 9-18 were immunoprecipitated with antibodies against the U5 and U4/U6.U5 tri-snRNP protein Snu114. RNA coprecipitating together with Snu114, as well as RNA remaining in the supernatant after immunoprecipitation, was analysed by denaturing PAGE followed by Northern blotting (to visualize the snRNAs) or autoradiography (to detect the radiolabelled pre-mRNA).
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Supplemental Figure 8 Figure S8 Characterization of spliceosomal complexes formed on a truncated ActΔ6 pre-mRNA. (A) Glycerol gradient sedimentation profile of MS2-MBP affinitypurified spliceosomal complexes formed on 32 P-labelled ActΔ6 pre-mRNA in extract from wt or Δsnu17 yeast cells after 60 min in the presence of 2 mM ATP. (B) RNA compositions of the affinity-purified complexes from the 45S peak fractions of the glycerol gradient. The pre-mRNA and snRNAs were separated by denaturing PAGE and detected as described in the legend to Figure S3 .
Supplemental Methods

Yeast Growth Assays
To assay the growth phenotypes of the wildtype, prp2-1 and prp2-1 Δsnu17 strains, yeast cells were grown at 25˚C in yeast extract/peptone medium (Formedium™) to an OD 600 of 4.0 and then collected by centrifugation. Yeast were then spotted after 10-fold serial dilutions on YPD plates and grown at 16˚C , 25˚C , 30˚C or 37˚C for 2-3 days.
Immunoprecipitations
Spliceosomal complexes were formed in extract from prp2-1 Δsnu17 yeast cells (after heat inactivation of Prp2) and subsequently affinity purified and subjected to glycerol gradient centrifugation. Spliceosomes in the 45S gradient peak (ΔRES B/B act -like complexes) were incubated with UTP, Prp2 and Spp2, and then analysed on a second glycerol gradient. For immunoprecipitation analysis, gradient fractions 9-18 were incubated with Protein A Sepharose bound by antibodies against the S. cerevisiae U5 Snu114 protein, with end-over-end rotation for 2 h. The supernatant was removed from the beads and the latter were 3X washed with NTN buffer [150 mM NaCl, 50 mM TrisHCl, pH 7.5, 0.1% Nonidet P40 (v/v)]. Both the beads and supernatants were then digested with proteinase K, and the RNA was recovered by phenol extraction followed by ethanol precipitation. Purified RNAs were separated by 8% PAGE and analyzed by Northern blotting.
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